Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non
Jnos Szentgothai Research Center, University of Pcs, Pcs, HungaryClinical Medicine Doctoral School, University of Szeged, Szeged, HungaryInstitute for Translational Medicine, Medical School, University of Pcs, Pcs, HungaryDivision of Cardiology and Angiology, First Department of Medicine, University of Pcs, Pcs, HungaryDivision of Gastroenterology, First Department of Medicine, Medical School, University of Pcs, Pcs, HungaryDivision of Hematology, First Department of Medicine, Medical School, University of Pcs, Pcs, HungaryDepartment of Biochemistry and Medical Chemistry, Medical School, University of Pcs, Pcs, HungaryInstitute of Bioanalysis, Medical School, University of Pcs, Pcs, HungaryDepartment of Laboratory Medicine, Medical School, University of Pcs, Pcs, HungaryAbstractIntroduction Haemorheological and haemostatic changes predispose to the development of arterial and venous thrombotic events; however, limited information is available on the replica hermes evelyne 17cm mini
status of these changes in coeliac disease (CeD) and inflammatory bowel disease (IBD). In this study, we aim to describe the haemorheological and haemostatic profiles of CeD and IBD patients in a Hungarian cohort of patients to investigate whether any alterations contribute to elevated thrombotic risk.
Methods and analysis This is a case control study involving newly diagnosed and followed CeD and IBD patients with age matched and sex matched non CeD, non IBD subjects with an allocation ratio of 1:1:1.
After informed consent is obtained, a detailed medical history will be collected, including venous and arterial thrombotic risk factors and medications. Symptoms in CeD patients will be assessed with the Gastrointestinal Symptoms Rating Scale, and disease activity in IBD patients will be determined by disease specific scores. Dietary adherence will be assessed among CeD patients with a thorough interview together with a measurement of self reported adherence, dietary knowledge and urine analysis (detection of gluten immunogenic peptides). In addition to routine laboratory parameters, haemorheological (ie, erythrocyte deformability and aggregation, viscosity of whole blood and plasma) and haemostatic parameters (eg, protein C, protein S and antithrombin) with immunological indicators (ie, coeliac specific serology and antiphospholipid antibodies) will be measured from venous blood for every participant.
Primary and secondary outcomes will be haemorheological and haemostatic parameters, respectively. Univariate and multivariate statistics will be used to compare CeD and IBD patients to control subjects. Subgroup analysis will be performed by disease type in IBD, (Crohn’s disease and ulcerose colitis), dietary adherence in CeD, and disease activity in IBD and CeD.
Ethics and dissemination The study was approved by the Regional and Local Research Ethics Committee, University of Pcs (Ref. No. 6917). Findings will be disseminated at research conferences and in peer reviewed journals.